ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

ClinicalTrials.gov ID: NCT01662492

Public ClinicalTrials.gov record NCT01662492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

191622-103 BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Adolescents (Children 12 to < 18 Years of Age) With Chronic Migraine

Study identification

NCT ID
NCT01662492
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
125 participants

Conditions and interventions

Interventions

  • Botulinum toxin type A Dose 1 Biological
  • Botulinum toxin type A Dose 2 Biological
  • Placebo (Normal Saline) Drug

Biological · Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2012
Primary completion
Jul 31, 2016
Completion
Jul 31, 2016
Last update posted
Sep 4, 2017

2012 – 2016

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
Fullerton Neurology and Headache Center Fullerton California 92835
The Research Center of Southern California Oceanside California 92056
San Francisco Clinical Research Center San Francisco California 94109
Stanford Hospital and Clinics Stanford California 94305
Associated Neurologists of Southern CT, P.C. Fairfield Connecticut 06824
New England Institute for Clinical Research Stamford Connecticut 06905
NW FL Clinical Research Group, LLC Gulf Breeze Florida 32561
Pediatric Neurology, PA Orlando Florida 32819
The Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida 33407
Advanced Clinical Research Meridian Idaho 83642
Josephson Wallack Munshower Neurology, P.C. Indianapolis Indiana 46237
CPFCC Neurology Research Department Overland Park Kansas 66212
Michigan Head Pain & Neurological Institute Ann Arbor Michigan 48104
CORE (Center for Outpatient Research) Springfield Missouri 65804
Renown Institution for Neurosciences Reno Nevada 89502
Rochester Clinical Research, Inc Rochester New York 14609
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Jill Waldo, CCRC Pittsburgh Pennsylvania 15236
Nashville Neuroscience Group Nashville Tennessee 37203
Texas Association of Pediatric Neurology/Road Runner Research San Antonio Texas 78258
Wasatch Clinical Research Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01662492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2017 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01662492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →